4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-20-030323
Chief Commercial Officer acquired 82,508 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vavricka John Chief Commercial Officer | 2020-11-03 | Conversion | +82,508 | 82,508 | I | ||
| Derivatives | |||||||
| Vavricka John Chief Commercial Officer | 2020-11-03 | Conversion · Series B Convertible Preferred Stock | −82,508 | 0 | I | ||
Loading xslF345X03/doc4.xml…